Sofia Fund portfolio company Oculogica achieves FDA milestone

Oculogica receives FDA Marketing Authorization for EyeBOX^®, the first non-invasive, baseline-free test for concussion. Oculogica is a pioneer in algorithm-based neurodiagnostics.

Click here to read more.